Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2834 | Patient management suffering of coronavirus infection Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D000077062 | Burnout, Psychological NIH | 0.24 |
| D013315 | Stress, Psychological NIH | 0.18 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
This is an interventional, pilot, multicenter, randomized, open-label, phase 2 study, enrolling patients with COVID-19 disease. One-month rate of entering the critical stage (either a. Respiratory failure occurs and requires mechanical ventilation; b. Patients combined with other organ failure need ICU monitoring and treatment; c. Death) is the primary endpoint.
Description: Comply with any of the followings: Respiratory failure occurs and requires mechanical ventilation; Patients combined with other organ failure need ICU monitoring and treatment Death
Measure: Rate of entering the critical stage Time: [1 month]Description: Comply with any of the followings: No fever, cough and other symptoms; SPO2>94% or PaO2/FiO2 >350mmHg without oxygen inhalation
Measure: Rate of disease remission Time: [up to 30 days]Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports